This comprehensive care bundle optimises menopause management through hormonal blood tests (FSH, oestradiol, lipids, thyroid function) and a transvaginal ultrasound to assess endometrial thickness and pelvic health. Hormone Replacement Therapy (HRT) regimens (systemic/local) are tailored based on symptom severity, medical history, and risk factors (e.g., osteoporosis, cardiovascular health) guiding preventive strategies to enhance safety, symptom relief, and long-term well-being. This care bundle aligns with NICE and British Menopause Society guidelines.
This fertility check bundle evaluates reproductive health review through hormonal blood tests (AMH, FSH, LH, thyroid) and a transvaginal ultrasound to assess ovarian reserve, follicle count, and uterine anatomy. This consultation aims identifying issues like PCOS, diminished ovarian reserve, or structural abnormalities. Designed for proactive couples or individuals, the bundle combines diagnostics, evidence-based strategies, and convenient care to address fertility barriers and enhance family-planning success. This care bundle aligns with the British Fertility Society and NICE fertility guidelines.
This care bundle monitors uterine fibroids through blood tests and transvaginal scans to track size, location, and complications (e.g., anaemia, pressure symptoms, degenerative or cancerous changes) to identify any variable type of fibroids guiding tailored interventions. Regular follow-ups assess fibroid changes and symptom progression to empower you with informed decisions on treatment options and fertility preservation. This care bundle aligns with NICE guidance and fibroid centre recommendations.
This comprehensive remote service provides extensive STI screening and management, covering seven sexually transmitted infections besides checking human papilloma and herpes viruses. Designed for accessibility and privacy, the bundle emphasizes early detection, prompt treatment, and patient empowerment, reducing STI transmission and long-term health complications through convenient, stigma-free care. This care bundle aligns with British Association for Sexual Health and HIV and College of Sexual and Reproductive Healthcare guidelines.
This advanced bundle combines the non-invasive Ziwig Endometriosis Test (salivary miRNA biomarker analysis) with a transvaginal ultrasound to enhance diagnostic accuracy for endometriosis. The Ziwig test evaluates genetic markers linked to the condition, while imaging identifies soft markers, lesions, endometriomas, or adhesions. Designed to reduce diagnostic delays, the bundle offers holistic, evidence-based care for timely intervention and improved quality of life. This care bundle aligns with European Society of Human Reproduction and Embryology guidelines.
This advanced diagnostic bundle enhances early detection of ovarian tumours by combining biomarker analysis and imaging. It includes HE4 and CA125 blood tests, integrated into the ROMA algorithm to stratify ovarian cancer risk, alongside a transvaginal ultrasound using ADNEX model for structural evaluation of ovaries/pelvis. Designed for accuracy and convenience, the bundle aids in distinguishing benign from malignant pathology, supporting timely intervention and improved outcomes through a proactive, evidence-based approach to ovarian health. This care bundle aligns with FIGO guidance and International Society of Gynaecologic Oncology
This streamlined bundle combines a consultation with transvaginal ultrasound and WID-Easy endometrial cancer detection test with or without endometrial biopsy to detect endometrial cancer early. The consultation evaluates symptoms (e.g., abnormal bleeding) and risk factors (obesity, diabetes, Lynch syndrome). TVS measures endometrial thickness and identifies structural abnormalities, while WID-Easy swab test detects tumour cells in vagina and biopsy provides histological confirmation of malignancy. This is an ideal preventive approach for any peri-menopausal or postmenopausal bleeding or high-risk individuals to guide timely intervention and reduces delays
This care bundle aligns with NICE and British Gynaecological Cancer Society guidance